{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:46:17Z","timestamp":1790261177736,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["PGSD3-438474-2013 (to TK)"],"award-info":[{"award-number":["PGSD3-438474-2013 (to TK)"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &amp; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5T32GM07616NSF (to NGS)"],"award-info":[{"award-number":["5T32GM07616NSF (to NGS)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["BWF.1014981"],"award-info":[{"award-number":["BWF.1014981"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jacobs Institute for Molecular Engineering for Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antimicrobial-resistant <jats:italic>Neisseria gonorrhoeae<\/jats:italic> is an urgent public-health threat, with continued worldwide incidents of infection and rising resistance to antimicrobials. Traditional culture-based methods for antibiotic susceptibility testing are unacceptably slow (1\u20132 days), resulting in the use of broad-spectrum antibiotics and the further development and spread of resistance. Critically needed is a rapid antibiotic susceptibility test (AST) that can guide treatment at the point-of-care. Rapid phenotypic approaches using quantification of DNA have been demonstrated for fast-growing organisms (e.g. <jats:italic>E<\/jats:italic>. <jats:italic>coli<\/jats:italic>) but are challenging for slower-growing pathogens such as <jats:italic>N<\/jats:italic>. <jats:italic>gonorrhoeae<\/jats:italic>. Here, we investigate the potential of RNA signatures to provide phenotypic responses to antibiotics in <jats:italic>N<\/jats:italic>. <jats:italic>gonorrhoeae<\/jats:italic> that are faster and greater in magnitude compared with DNA. Using RNA sequencing, we identified antibiotic-responsive transcripts. Significant shifts (&gt;4-fold change) in transcript levels occurred within 5\u2009min of antibiotic exposure. We designed assays for responsive transcripts with the highest abundances and fold changes, and validated gene expression using digital PCR. Using the top two markers (<jats:italic>porB<\/jats:italic> and <jats:italic>rpmB<\/jats:italic>) we correctly determined the antibiotic susceptibility and resistance of 49 clinical isolates after 10\u2009min exposure to ciprofloxacin. RNA signatures are therefore promising as an approach on which to build rapid AST devices for <jats:italic>N<\/jats:italic>. <jats:italic>gonorrhoeae<\/jats:italic> at the point-of-care, which is critical for disease management, surveillance, and antibiotic stewardship efforts.<\/jats:p>","DOI":"10.1038\/s41598-018-29707-w","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T10:07:37Z","timestamp":1532686057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["RNA markers enable phenotypic test of antibiotic susceptibility in Neisseria gonorrhoeae after 10\u2009minutes of ciprofloxacin exposure"],"prefix":"10.1038","volume":"8","author":[{"given":"Tahmineh","family":"Khazaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob T.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan G.","family":"Schoepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3680-4399","authenticated-orcid":false,"given":"Rustem F.","family":"Ismagilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"29707_CR1","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2016 (2017)."},{"key":"29707_CR2","unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae (2012)."},{"key":"29707_CR3","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013 (2013)."},{"key":"29707_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo, M. et al. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56, 1273\u20131280 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29707_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3201\/eid1701.100397","volume":"17","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi, M. et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg. Infect. Dis. 17, 148 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"29707_CR6","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1056\/NEJMc1408109","volume":"371","author":"MM Lahra","year":"2014","unstructured":"Lahra, M. M., Ryder, N. & Whiley, D. M. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N. Engl. J. Med. 371, 1850\u20131851 (2014).","journal-title":"N. Engl. J. Med."},{"key":"29707_CR7","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J C\u00e1mara","year":"2012","unstructured":"C\u00e1mara, J. et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J. Antimicrob. Chemother. 67, 1858\u20131860 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"29707_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3201\/eid2201.150868","volume":"22","author":"T Deguchi","year":"2016","unstructured":"Deguchi, T. et al. New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan. Emerg. Infect. Dis. 22, 142 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"29707_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1128\/JCM.03032-15","volume":"54","author":"P Hemarajata","year":"2016","unstructured":"Hemarajata, P., Yang, S., Soge, O., Humphries, R. & Klausner, J. Performance and verification of a real-time PCR assay targeting the gyrA gene for prediction of ciprofloxacin resistance in Neisseria gonorrhoeae. J. Clin. Microbiol. 54, 805\u2013808 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"29707_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/jac\/dkv432","volume":"71","author":"MJ Pond","year":"2016","unstructured":"Pond, M. J. et al. Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy. J. Antimicrob. Chemother. 71, 897\u2013902 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"29707_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1046\/j.1365-2958.2002.03265.x","volume":"46","author":"FE Aas","year":"2002","unstructured":"Aas, F. E., L\u00f8vold, C. & Koomey, M. An inhibitor of DNA binding and uptake events dictates the proficiency of genetic transformation in Neisseria gonorrhoeae: mechanism of action and links to type IV pilus expression. Mol. Microbiol. 46, 1441\u20131450 (2002).","journal-title":"Mol. Microbiol."},{"key":"29707_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2958.2005.04964.x","volume":"59","author":"HL Hamilton","year":"2006","unstructured":"Hamilton, H. L. & Dillard, J. P. Natural transformation of Neisseria gonorrhoeae: from DNA donation to homologous recombination. Mol. Microbiol. 59, 376\u2013385 (2006).","journal-title":"Mol. Microbiol."},{"key":"29707_CR13","doi-asserted-by":"crossref","unstructured":"Baltekin, \u00d6., Boucharin, A., Tano, E., Andersson, D. I. & Elf, J. Antibiotic susceptibility testing in less than 30 min using direct single-cell imaging. Proc. Natl. Acad. Sci. USA, 201708558 (2017).","DOI":"10.1073\/pnas.1708558114"},{"key":"29707_CR14","doi-asserted-by":"publisher","first-page":"e5470","DOI":"10.1371\/journal.pone.0005470","volume":"4","author":"T-T Liu","year":"2009","unstructured":"Liu, T.-T. et al. A high speed detection platform based on surface-enhanced Raman scattering for monitoring antibiotic-induced chemical changes in bacteria cell wall. PloS One 4, e5470 (2009).","journal-title":"PloS One"},{"key":"29707_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1469-0691.2012.03800.x","volume":"19","author":"M Broeren","year":"2013","unstructured":"Broeren, M., Maas, Y., Retera, E. & Arents, N. Antimicrobial susceptibility testing in 90 min by bacterial cell count monitoring. Clin. Microbiol. Infect. 19, 286\u2013291 (2013).","journal-title":"Clin. Microbiol. Infect."},{"key":"29707_CR16","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1128\/JCM.00440-13","volume":"51","author":"M Fredborg","year":"2013","unstructured":"Fredborg, M. et al. Real-time optical antimicrobial susceptibility testing. J. Clin. Microbiol. 51, 2047\u20132053 (2013).","journal-title":"J. Clin. Microbiol."},{"issue":"1.1-4A","key":"29707_CR17","first-page":"1.26","volume":"4A","author":"JM Spence","year":"2008","unstructured":"Spence, J. M., Wright, L. & Clark, V. L. Laboratory maintenance of Neisseria gonorrhoeae. Curr. Protoc. Microbiol. 4A(1.1-4A), 1.26 (2008).","journal-title":"Curr. Protoc. Microbiol."},{"key":"29707_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1128\/JCM.02434-14","volume":"53","author":"A Mezger","year":"2015","unstructured":"Mezger, A. et al. A general method for rapid determination of antibiotic susceptibility and species in bacterial infections. J. Clin. Microbiol. 53, 425\u2013432 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"29707_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/jac\/dkh324","volume":"54","author":"J Rolain","year":"2004","unstructured":"Rolain, J., Mallet, M., Fournier, P. & Raoult, D. Real-time PCR for universal antibiotic susceptibility testing. J. Antimicrob. Chemother. 54, 538\u2013541 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"29707_CR20","doi-asserted-by":"publisher","first-page":"eaal3693","DOI":"10.1126\/scitranslmed.aal3693","volume":"9","author":"NG Schoepp","year":"2017","unstructured":"Schoepp, N. G. et al. Rapid pathogen-specific phenotypic antibiotic susceptibility testing using digital LAMP quantification in clinical samples. Sci. Transl. Med. 9, eaal3693 (2017).","journal-title":"Sci. Transl. Med."},{"key":"29707_CR21","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1371\/journal.pbio.0040185","volume":"4","author":"DM Tobiason","year":"2006","unstructured":"Tobiason, D. M. & Seifert, H. S. The obligate human pathogen, Neisseria gonorrhoeae, is polyploid. PLoS Biol. 4, e185 (2006).","journal-title":"PLoS Biol."},{"key":"29707_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0022-2836(68)90425-7","volume":"31","author":"S Cooper","year":"1968","unstructured":"Cooper, S. & Helmstetter, C. E. Chromosome replication and the division cycle of Escherichia coli Br. J. Mol. Biol. 31, 519\u2013540 (1968).","journal-title":"J. Mol. Biol."},{"key":"29707_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-4-r32","volume":"7","author":"DP Sangurdekar","year":"2006","unstructured":"Sangurdekar, D. P., Srienc, F. & Khodursky, A. B. A classification based framework for quantitative description of large-scale microarray data. Genome Biol. 7, R32 (2006).","journal-title":"Genome Biol."},{"key":"29707_CR24","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1073\/pnas.1119540109","volume":"109","author":"AK Barczak","year":"2012","unstructured":"Barczak, A. K. et al. RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities. Proc. Natl. Acad. Sci. USA 109, 6217\u20136222 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"29707_CR25","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1093\/ofid\/ofx162.082","volume":"4","author":"R Bhattacharyya","year":"2017","unstructured":"Bhattacharyya, R. et al. Rapid Phenotypic Antibiotic Susceptibility Testing Through RNA Detection. Open Forum Infect. Dis. 4, S33\u2013S33, https:\/\/doi.org\/10.1093\/ofid\/ofx162.082 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"29707_CR26","doi-asserted-by":"publisher","first-page":"e0133982","DOI":"10.1371\/journal.pone.0133982","volume":"10","author":"R McClure","year":"2015","unstructured":"McClure, R. et al. The gonococcal transcriptome during infection of the lower genital tract in women. PloS One 10, e0133982 (2015).","journal-title":"PloS One"},{"key":"29707_CR27","doi-asserted-by":"publisher","first-page":"10579","DOI":"10.1093\/nar\/gku762","volume":"42","author":"CW Remmele","year":"2014","unstructured":"Remmele, C. W. et al. Transcriptional landscape and essential genes of Neisseria gonorrhoeae. Nucleic Acids Res. 42, 10579\u201310595 (2014).","journal-title":"Nucleic Acids Res."},{"key":"29707_CR28","doi-asserted-by":"publisher","first-page":"e17101","DOI":"10.1371\/journal.pone.0017101","volume":"6","author":"EA Stohl","year":"2011","unstructured":"Stohl, E. A., Gruenig, M. C., Cox, M. M. & Seifert, H. S. Purification and characterization of the RecA protein from Neisseria gonorrhoeae. PloS One 6, e17101 (2011).","journal-title":"PloS One"},{"key":"29707_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1365-2958.2010.07491.x","volume":"79","author":"PO Schook","year":"2011","unstructured":"Schook, P. O., Stohl, E. A., Criss, A. K. & Seifert, H. S. The DNA\u2010binding activity of the Neisseria gonorrhoeae LexA orthologue NG1427 is modulated by oxidation. Mol. Microbiol. 79, 846\u2013860 (2011).","journal-title":"Mol. Microbiol."},{"key":"29707_CR30","unstructured":"Qin, T.-T. et al. SOS response and its regulation on the fluoroquinolone resistance. Ann. Transl. Med. 3 (2015)."},{"key":"29707_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0378-1119(97)00653-7","volume":"208","author":"CG Black","year":"1998","unstructured":"Black, C. G., Fyfe, J. A. & Davies, J. K. Absence of an SOS-like system in Neisseria gonorrhoeae. Gene 208, 61\u201366 (1998).","journal-title":"Gene"},{"key":"29707_CR32","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1128\/JB.00801-06","volume":"188","author":"EA Stohl","year":"2006","unstructured":"Stohl, E. A. & Seifert, H. S. Neisseria gonorrhoeae DNA recombination and repair enzymes protect against oxidative damage caused by hydrogen peroxide. J. Bacteriol. 188, 7645\u20137651 (2006).","journal-title":"J. Bacteriol."},{"key":"29707_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/j.1875-9114.1988.tb04058.x","volume":"8","author":"M LeBel","year":"1988","unstructured":"LeBel, M. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 8, 3\u201330 (1988).","journal-title":"Pharmacotherapy"},{"key":"29707_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1099\/mic.0.27539-0","volume":"151","author":"Q Gao","year":"2005","unstructured":"Gao, Q. et al. Gene expression diversity among Mycobacterium tuberculosis clinical isolates. Microbiology 151, 5\u201314 (2005).","journal-title":"Microbiology"},{"key":"29707_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro.2017.169","volume":"16","author":"SJ Quillin","year":"2018","unstructured":"Quillin, S. J. & Seifert, H. S. Neisseria gonorrhoeae host adaptation and pathogenesis. Nat. Rev. Microbiol. 16, 226\u2013240 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"29707_CR36","doi-asserted-by":"publisher","first-page":"e41356","DOI":"10.1371\/journal.pone.0041356","volume":"7","author":"JM Zook","year":"2012","unstructured":"Zook, J. M., Samarov, D., McDaniel, J., Sen, S. K. & Salit, M. Synthetic spike-in standards improve run-specific systematic error analysis for DNA and RNA sequencing. PloS One 7, e41356 (2012).","journal-title":"PloS One"},{"key":"29707_CR37","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Ciprofloxacin\/Neisseria gonorrhoeae International MIC Distribution - Reference Database 2018-04-03. https:\/\/mic.eucast.org\/Eucast2\/regShow.jsp?Id=35702 (2018)."},{"key":"29707_CR38","doi-asserted-by":"crossref","unstructured":"Gomez, J. E. et al. Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. Elife 6 (2017).","DOI":"10.7554\/eLife.20420"},{"key":"29707_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/CMR.00043-12","volume":"25","author":"L Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez, L. & Hancock, R. E. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 25, 661\u2013681 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"29707_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye, J. et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13, 134 (2012).","journal-title":"BMC Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29707-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29707-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29707-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:00:04Z","timestamp":1671609604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29707-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29707"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29707-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The technology described in this publication is the subject of a patent application filed by Caltech. R.F.I. has a financial interest in Talis Biomedical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11606"}}